<DOC>
	<DOCNO>NCT00776295</DOCNO>
	<brief_summary>The purpose study determine whether p53 vaccination follow high dose chemotherapy autologous HCT T cell therapy significantly induce immune response result 1-year survival great current 70 % .</brief_summary>
	<brief_title>Autologous SCT Followed Dendritic Cell p53 Vaccination Patients With Limited Stage Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Histologically confirm SCLC present Limited Stage ( LS ) diagnosis . Measurable disease time initial therapy Appropriate treatment LSSCLC include radiotherapy chemotherapy . Responsive disease standard chemoradiation therapy define RECIST Patients CR chemoradiation therapy strongly recommend treat prophylactic cranial irradiation CBC absolute neutrophil count ( ANC ) &gt; /= 1,000/uL , hemoglobin &gt; /= 8.0 g/DL platelet count &gt; /= 75,000/uL . Normal prothrombin time ( PT ) partial thromboplastin time ( aPTT ) , unless monitor anticoagulation therapy medical condition exclude trial . Liver enzymes : total bilirubin less equal 2mg/dL ; AST ALT le 1.5X upper limit normal . Creatinine clearance &gt; /= 60 mL/min Pulmonary : DLCO great 50 % Cardiac : leave ventricular ejection fraction great 45 % Patient stable ( SD ) progressive disease ( PD ) 4 cycle standard cisplatin etoposide concurrent chest irradiation Pregnant lactate woman HIV infection confirm NAT Common variable immunodeficiency Active CNS malignancy Active bacterial , fungal viral infection Unfavorable psychosocial evaluation history poor compliance prescribe medical care Prior history autologous allogeneic hematopoietic cell transplantation Presence protocol specific comorbid condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Small Cell Lung Cancer</keyword>
	<keyword>SCLC</keyword>
	<keyword>Limited Stage Small Cell Lung Cancer</keyword>
</DOC>